Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 5 (TTC5) is a conserved protein containing multiple tetratricopeptide repeat (TPR) motifs, which are structural domains mediating protein–protein interactions and the assembly of multiprotein complexes[2][5]. TTC5 acts as a transcriptional cofactor and adaptor protein, regulating key cellular processes such as the DNA damage response, TP53/p53 stabilization and activation, heat-shock response, chromatin modification, autophagy, actin dynamics, and mRNA catabolism[3][4][5]. In stress conditions, TTC5 forms complexes with the histone acetyltransferase p300 (EP300) and coactivators like JMY to facilitate the activation of p53-dependent gene expression, promoting cell cycle arrest or apoptosis after DNA damage[3][4][5]. TTC5 is also required for survival and self-renewal of acute myeloid leukemia (AML) cells, acting partly through positive regulation of anti-apoptotic BCL2 expression and suppression of pro-apoptotic gene expression, in cooperation with p300/EP300[3]. TTC5 is broadly expressed, including in hematopoietic tissues; its dysfunction is associated with neurodevelopmental disorders and intellectual disability[4]. No approved drugs directly target TTC5, but its critical roles in apoptosis and cancer reveal potential therapeutic interest, particularly in hematological malignancies[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 5 (TTC5).